423 related articles for article (PubMed ID: 29696624)
1. Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.
Krug S; Abbassi R; Griesmann H; Sipos B; Wiese D; Rexin P; Blank A; Perren A; Haybaeck J; Hüttelmaier S; Rinke A; Gress TM; Michl P
Int J Cancer; 2018 Oct; 143(7):1806-1816. PubMed ID: 29696624
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer.
Griesmann H; Drexel C; Milosevic N; Sipos B; Rosendahl J; Gress TM; Michl P
Gut; 2017 Jul; 66(7):1278-1285. PubMed ID: 27013602
[TBL] [Abstract][Full Text] [Related]
3. Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model.
Bill R; Fagiani E; Zumsteg A; Antoniadis H; Johansson D; Haefliger S; Albrecht I; Hilberg F; Christofori G
Clin Cancer Res; 2015 Nov; 21(21):4856-67. PubMed ID: 26206868
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic Therapy in Pancreatic Neuroendocrine Tumors.
Capozzi M; VON Arx C; DE Divitiis C; Ottaiano A; Tatangelo F; Romano GM; Tafuto S;
Anticancer Res; 2016 Oct; 36(10):5025-5030. PubMed ID: 27798861
[TBL] [Abstract][Full Text] [Related]
5. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach.
Zeisberger SM; Odermatt B; Marty C; Zehnder-Fjällman AH; Ballmer-Hofer K; Schwendener RA
Br J Cancer; 2006 Aug; 95(3):272-81. PubMed ID: 16832418
[TBL] [Abstract][Full Text] [Related]
6. Autophagy Inhibition Improves Sunitinib Efficacy in Pancreatic Neuroendocrine Tumors via a Lysosome-dependent Mechanism.
Wiedmer T; Blank A; Pantasis S; Normand L; Bill R; Krebs P; Tschan MP; Marinoni I; Perren A
Mol Cancer Ther; 2017 Nov; 16(11):2502-2515. PubMed ID: 28729403
[TBL] [Abstract][Full Text] [Related]
7. Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinoma.
Olson P; Chu GC; Perry SR; Nolan-Stevaux O; Hanahan D
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1275-84. PubMed ID: 22084065
[TBL] [Abstract][Full Text] [Related]
8. Periostin Limits Tumor Response to VEGFA Inhibition.
Keklikoglou I; Kadioglu E; Bissinger S; Langlois B; Bellotti A; Orend G; Ries CH; De Palma M
Cell Rep; 2018 Mar; 22(10):2530-2540. PubMed ID: 29514082
[TBL] [Abstract][Full Text] [Related]
9. Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms.
Pozas J; San Román M; Alonso-Gordoa T; Pozas M; Caracuel L; Carrato A; Molina-Cerrillo J
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597249
[TBL] [Abstract][Full Text] [Related]
10. A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects.
Piaggio F; Kondylis V; Pastorino F; Di Paolo D; Perri P; Cossu I; Schorn F; Marinaccio C; Murgia D; Daga A; Raggi F; Loi M; Emionite L; Ognio E; Pasparakis M; Ribatti D; Ponzoni M; Brignole C
J Control Release; 2016 Feb; 223():165-177. PubMed ID: 26742942
[No Abstract] [Full Text] [Related]
11. Macrophages Promote Growth of Squamous Cancer Independent of T cells.
Wu FL; Nolan K; Strait AA; Bian L; Nguyen KA; Wang JH; Jimeno A; Zhou HM; Young CD; Wang XJ
J Dent Res; 2019 Jul; 98(8):896-903. PubMed ID: 31189369
[TBL] [Abstract][Full Text] [Related]
12. mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors.
Lewis CS; Elnakat Thomas H; Orr-Asman MA; Green LC; Boody RE; Matiash K; Karve A; Hisada YM; Davis HW; Qi X; Mercer CA; Lucas FV; Aronow BJ; Mackman N; Versteeg HH; Bogdanov VY
J Thromb Haemost; 2019 Jan; 17(1):169-182. PubMed ID: 30472780
[TBL] [Abstract][Full Text] [Related]
13. DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization.
Downey CM; Aghaei M; Schwendener RA; Jirik FR
PLoS One; 2014; 9(6):e99988. PubMed ID: 24940883
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages.
Hattori Y; Yamashita J; Sakaida C; Kawano K; Yonemochi E
J Liposome Res; 2015; 25(2):131-40. PubMed ID: 25203609
[TBL] [Abstract][Full Text] [Related]
15. The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
Licarete E; Rauca VF; Luput L; Patras L; Sesarman A; Banciu M
Oncol Rep; 2019 Dec; 42(6):2694-2705. PubMed ID: 31578578
[TBL] [Abstract][Full Text] [Related]
16. Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.
Reusser NM; Dalton HJ; Pradeep S; Gonzalez-Villasana V; Jennings NB; Vasquez HG; Wen Y; Rupaimoole R; Nagaraja AS; Gharpure K; Miyake T; Huang J; Hu W; Lopez-Berestein G; Sood AK
Cancer Biol Ther; 2014 Aug; 15(8):1061-7. PubMed ID: 24841852
[TBL] [Abstract][Full Text] [Related]
17. CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms.
Krug S; Kühnemuth B; Griesmann H; Neesse A; Mühlberg L; Boch M; Kortenhaus J; Fendrich V; Wiese D; Sipos B; Friemel J; Gress TM; Michl P
Endocr Relat Cancer; 2014; 21(6):879-90. PubMed ID: 25248790
[TBL] [Abstract][Full Text] [Related]
18. Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype.
Piña Y; Boutrid H; Murray TG; Jager MJ; Cebulla CM; Schefler A; Ly LV; Alegret A; Celdran M; Feuer W; Jockovich ME
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2671-7. PubMed ID: 20053982
[TBL] [Abstract][Full Text] [Related]
19. Combined MEK inhibition and tumor-associated macrophages depletion suppresses tumor growth in a triple-negative breast cancer mouse model.
Zhang Q; Le K; Xu M; Zhou J; Xiao Y; Yang W; Jiang Y; Xi Z; Huang T
Int Immunopharmacol; 2019 Nov; 76():105864. PubMed ID: 31480004
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors.
Bisht S; Feldmann G; Brossart P
Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):777-88. PubMed ID: 23590356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
